MAPT and frontotemporal dementia: Given the prevalence of co-pathologies (i.e., concomitant Tau and pTDP-43 pathology) previously reported in the amygdala of patients with frontotemporal lobar degeneration (FTLD) (19), we also characterised phospho-Tau (pTau) burden in our sALS cohort using the AT8 monoclonal antibody (Figure 3).